Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1Phase 1 1

Status

Unknown 5Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Thoracic 5

Conditions

Carcinoma, Non-Small-Cell Lung 5Neoplasms 3Vascular Diseases 2Heart Diseases 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Neoplasms, Second Primary 1Metabolic Diseases 1Heart Failure 1Drug-Related Side Effects and Adverse Reactions 1Colorectal Cancer Metastatic 1Cardiovascular Diseases 1Cardiotoxicity 1Cancer Therapy-related Cardiovascular Toxicity 1Breast Neoplasms 1Advanced Ovarian Cancer 1

Interventions

Carboplatin 84Cisplatin 79Pemetrexed 72Docetaxel 62Drug Therapy 44Gemcitabine 43Erlotinib Hydrochloride 42Gefitinib 38Radiotherapy 36Paclitaxel 36pembrolizumab 31Bevacizumab 29icotinib 28osimertinib 27anlotinib 26Nivolumab 26camrelizumab 23Vinorelbine 23Radiosurgery 20aumolertinib 18atezolizumab 17sintilimab 16apatinib 16Endostatins 16endostar protein 15durvalumab 14Surgical Procedures, Operative 13Immunotherapy 13Immune Checkpoint Inhibitors 12Blood Specimen Collection 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Non-Small-Cell Lung × Antineoplastic Agents × Clear all
NCT06357598 2024-04-10

PILOT

The Affiliated Hospital of Qingdao University

Phase 4 Unknown
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05573373 2024-01-31

Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer

Affiliated Hospital of Jiangnan University

Phase 1 Unknown
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05486988 2022-08-04

ctDNA as a Biomarker for Treatment in Advanced NSCLC

Fuzhou General Hospital

Unknown
500 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04943029 2021-09-02

NEOSUN

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Unknown
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04115410 2020-05-28

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Sungkyunkwan University

Unknown
4,724 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡